医学
肝内胆管癌
肝切除术
转移
吉西他滨
恶性肿瘤
化疗
肺
肝肿瘤
放射科
外科
癌症
胃肠病学
内科学
肝细胞癌
切除术
作者
KAZUKI MATSUMURA,Kensuke Yamamura,ERI ODA,Shinichi Akahoshi,TAKATOSHI ISHIKO,Tatsunori Miyata,HIDEAKI MIYAMOTO,Toshihiko Motohara,AKIRA SASAO,Yoshihiro Komohara,HIDECHIKA KAWANO,Toru Beppu
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2022-05-31
卷期号:42 (6): 3209-3215
标识
DOI:10.21873/anticanres.15811
摘要
Background/Aim: Intrahepatic cholangiocarcinoma (ICC) is increasing in incidence and has a poor prognosis. Case Report: A 79-year-old woman with two liver tumors was referred to our institution. The tumors demonstrated irregular margins and continuous peripheral enhancement. She had a good liver function and an elevated CA19-9 level. Extended left hepatectomy, and partial hepatectomy was performed. The patient was diagnosed with poorly differentiated ICC. Two lung metastases, one liver metastasis, and localized intraperitoneal dissemination occurred 19, 24, and 32 months after the initial hepatectomy. The lung metastases were treated with computed tomography-guided radiofrequency ablation approximately after one year of observation. The liver metastasis was resected immediately. The peritoneal dissemination was removed entirely after effective 3-month chemotherapy using gemcitabine and S-1. The patient is alive with no tumor 44 months after the first surgery. Conclusion: Multidisciplinary treatment considering a metastatic site and tumor malignancy might be effective for patients with ICC who have multiple recurrences.
科研通智能强力驱动
Strongly Powered by AbleSci AI